Quote:

---

it seems to me you could come up with "a number to date and still calculating" and compare with SOC even if they are also "a number to date and still calculating" and have a reasonable comparison. Seems like waiting for all living sujects to die of old age before calculating would be stupid and missing out on useful information.

---

For comparisons to other drugs you'd use median overall survival. Initially Trodelvy claimed 11.8 months. When they reworked the data including patients no longer in the study the median real world overall survival was 10 months. With leronlimab all we know at this point is the median overall survival was over 12 months. We'll find out the true number on May 15th.